Management of Two-Week Dry Cough with Nocturnal Worsening in a 78-Year-Old Woman
This patient most likely has postinfectious cough following a viral upper respiratory infection, and should be treated with a trial of inhaled ipratropium bromide as first-line therapy. 1
Clinical Classification
At two weeks duration, this cough is classified as subacute (lasting 3-8 weeks following an acute respiratory infection). The pattern of symptoms—starting with a runny nose that resolved, followed by persistent dry cough and sore throat worsening at bedtime—is classic for postinfectious cough 1.
Key Diagnostic Considerations
The nocturnal worsening pattern raises three important possibilities that must be evaluated:
- Postinfectious cough (most likely given the timeline and preceding URI)
- Gastroesophageal reflux disease (GERD) - the nighttime worsening and sore throat are suggestive
- Upper airway cough syndrome (UACS) - though the resolved runny nose makes this less likely now
Important caveat: At 78 years old, you must first rule out serious conditions. Check for red flags including hemoptysis, significant dyspnea, systemic symptoms (fever, weight loss), or abnormal lung examination 2.
Initial Evaluation Required
Perform these specific assessments:
- Medication review: Confirm she is not taking ACE inhibitors (common cause of chronic dry cough) 3, 4
- Smoking status: Active smoking is a dose-related cause of persistent cough 3
- Chest radiograph: Essential to exclude pneumonia, malignancy, or other structural disease 2, 4
- Physical examination: Listen specifically for wheezing (asthma), crackles (pneumonia), or signs of heart failure 5
Treatment Algorithm
First-Line Treatment (Weeks 2-4)
Start inhaled ipratropium bromide - This has fair evidence for attenuating postinfectious cough 1. This addresses the mucus hypersecretion and impaired mucociliary clearance that characterizes postinfectious cough.
If No Improvement After 2 Weeks
Given the nocturnal pattern, add empiric GERD therapy:
- Proton pump inhibitor: Omeprazole 20-40 mg twice daily before meals for minimum 8 weeks (not just 2-4 weeks) 3
- Prokinetic agent: Consider metoclopramide 10 mg three times daily 3
- Dietary modifications: Avoid late meals, elevate head of bed
Critical point: The ineffectiveness of short-term PPI trials does NOT exclude GERD as a cause—treatment requires at least 8 weeks and often needs prokinetic agents 3, 6.
If Still No Improvement (Week 4-6)
Add inhaled corticosteroids when cough adversely affects quality of life and persists despite ipratropium 1. This addresses the bronchial hyperresponsiveness component of postinfectious cough.
For Severe Symptoms
If cough is severely affecting quality of life, consider prednisone 30-40 mg daily for a short finite period after ruling out other common causes 1.
Last Resort
Central antitussives (codeine or dextromethorphan) only when other measures fail 1.
What NOT to Do
- Do NOT prescribe antibiotics - postinfectious cough is not due to bacterial infection and antibiotics have no role 1
- Do NOT stop treatment prematurely - GERD treatment requires minimum 8 weeks, not the typical 2-4 weeks 3
- Do NOT assume PPI failure excludes GERD - nonacid reflux may be present and requires different management 5, 6
Follow-Up Schedule
Reassess in 4-6 weeks with validated cough severity tools 2, 4. If cough persists beyond 8 weeks total duration, it becomes chronic cough and requires expanded differential diagnosis including asthma, nonasthmatic eosinophilic bronchitis, and consideration of spirometry and exhaled nitric oxide testing 4.
Special Considerations for This Patient
At 78 years old, be particularly vigilant for:
- Pertussis: If paroxysmal coughing, post-tussive vomiting, or whooping develops, obtain nasopharyngeal culture 1
- Aspiration: The nocturnal pattern could suggest silent aspiration, particularly if GERD is present 6
- Medication-induced: Review all medications, not just ACE inhibitors—DPP-4 inhibitors (sitagliptin) also cause cough 2
The key to success is sequential, additive therapy with adequate treatment duration—most treatment failures result from stopping interventions too early or not addressing multiple contributing factors simultaneously 5.